Outlook Therapeutics (41O) Cash flow

7 Followers

Outlook Therapeutics Cash Flow

DE:41O's free cash flow for Q2 2026 was $-7.83M. For the 2026 fiscal year, DE:41O's free cash flow was decreased by $16.96M and operating cash flow was $-7.83M. See a summary of the company’s cash flow.

Cash Flow	Sep 25	Sep 24	Sep 23	Sep 22	Sep 21
Operating Cash Flow	$ -51.83M	$ -68.79M	$ -42.97M	$ -56.67M	$ -54.25M
Investing Cash Flow	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 44.98M	$ 60.33M	$ 48.97M	$ 59.59M	$ 56.19M
End Cash Position	$ 8.08M	$ 14.93M	$ 23.39M	$ 17.40M	$ 14.48M
Free Cash Flow	$ -51.83M	$ -68.79M	$ -42.97M	$ -56.67M	$ -54.25M

Currency in USD